SPECGX LLC FDA Approval ANDA 075629

ANDA 075629

SPECGX LLC

FDA Drug Application

Application #075629

Documents

Letter2000-05-09
Other Important Information from FDA2011-12-20
Review2001-12-05

Application Sponsors

ANDA 075629SPECGX LLC

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET, EXTENDED RELEASE;ORAL10MG0METHYLIN ERMETHYLPHENIDATE HYDROCHLORIDE
002TABLET, EXTENDED RELEASE;ORAL20MG0METHYLIN ERMETHYLPHENIDATE HYDROCHLORIDE

FDA Submissions

ORIG1AP2000-05-09
LABELING; LabelingSUPPL7AP2010-12-10
LABELING; LabelingSUPPL8AP2012-12-19
LABELING; LabelingSUPPL10AP2014-01-21STANDARD
LABELING; LabelingSUPPL12AP2015-03-20STANDARD
LABELING; LabelingSUPPL13AP2016-10-28STANDARD
LABELING; LabelingSUPPL15AP2016-10-28STANDARD
LABELING; LabelingSUPPL18AP2021-06-14STANDARD
LABELING; LabelingSUPPL20AP2021-06-14STANDARD
LABELING; LabelingSUPPL23AP2021-06-25STANDARD

Submissions Property Types

SUPPL8Null15
SUPPL10Null15
SUPPL12Null7
SUPPL13Null7
SUPPL15Null7
SUPPL18Null15
SUPPL20Null15
SUPPL23Null7

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

SPECGX LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 75629
            [companyName] => SPECGX LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"METHYLIN ER","activeIngredients":"METHYLPHENIDATE HYDROCHLORIDE","strength":"10MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"METHYLIN ER","activeIngredients":"METHYLPHENIDATE HYDROCHLORIDE","strength":"20MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"METHYLIN ER","submission":"METHYLPHENIDATE HYDROCHLORIDE","actionType":"10MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"METHYLIN ER","submission":"METHYLPHENIDATE HYDROCHLORIDE","actionType":"20MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.